Impact of bcr-abl1 transcript type on response, treatment-free remission rate and survival in chronic myeloid leukemia patients treated with imatinib

1. Marcé, S.
2. Xicoy, B.
3. García, O.
4. Cabezón, M.
5. Estrada, N.
6. Vélez, P.
7. Boqué, C.
8. Sagüés, M.
9. Angona, A.
10. Teruel-Montoya, R.
11. Ferrer-Marín, F.
12. Amat, P.
13. Hernández-Boluda, J.C.
14. Ibarra, M.M.
15. Anguita, E.
16. Cortés, M.
17. Fernández-Ruiz, A.
18. Fontanals, S.
19. Zamora, L.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3390/JCM10143146 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus